Stories
-
Hetero starts the supply of a generic version of Remdesivir – A Coronavirus Drug ‘Covifor’
Remdesivir is the first drug shown to help fight COVID-19. It reduces the recovery time of the COVID patient. The…
Read More » -
Why the U.S. needs international students – Trumps Administration scraps new visa order for many foreign students
Last week, Trump gave a very clear-headed message for all the international students in the U.S, saying that they wouldn’t…
Read More » -
Biocon’s Itolizumab, COVID-19 drug got approved by DGCA; just after 30 human trials…
Drugs Controller General of India (DCGI) approved biopharmaceuticals company Biocon’s Itolizumab (ALZUMAb) which is a plaque psoriasis drug as an…
Read More » -
Google to pick 7.7 pc stake in Jio for Rs 33,737 crore
Google will pick up 7.7 per cent stake in Reliance Industries’ technology venture for Rs 33,737 crore, richest Indian Mukesh…
Read More » -
Jio developing homegrown 5G telecom solution: Ambani
Richest Indian Mukesh Ambani on Wednesday announced his group’s digital arm Jio developing a homegrown 5G telecom solution. “Jio has…
Read More » -
Favipiravir Approved as Anti- COVID-19 Drug; DCGI Approves Influenza Treatment Drug For Covid-19 Treatment In India
Behind the drugs: The Drug Controller General of India has approved the use of favipiravir – an antiviral drug commonly…
Read More » -
COVID-19 Outbreak: Lockdown Again in India! Here All You need to Know About Which Places are Locking Down Again?
In the wake of an increasing number of coronavirus cases, several state governments have so far imposed lockdown again in…
Read More » -
Twitter erupts in chaos over Shivaji joke by comedian; received rape and death threats
If any of you, with even the remotest sense of humor, have seen the viral clip of a sketch performed…
Read More » -
Covid impact 2020: Drop in consumer goods sales due to localised lockdown in the country
Covid impact 2020: Drop in consumer goods sales due to localised lockdown in the country Huge manufacturers and retailer sellers…
Read More » -
US COVID-19 Vaccine Candidate Shows ‘Promising Results’ – Is It Too Early To Celebrate?
The first US COVID-19 vaccine to be approved on human trials is the Moderna vaccine candidate, mRNA- 1237. Moderna vaccine…
Read More »